With PD‐1/PD‐L1 blockade therapies, the overall survival and the progression‐free survival (PFS) rates were significantly elevated in cases with epithelial tumors whom did not consume antimicrobials for routine purposes compared to cases with tumor that received antibiotics.108. This evidence concerns the gene PDCD1 and neoplasm.